文献速递糖尿病

新诊断2型糖尿病患者抑郁症状与糖尿病痛苦对2年血糖控制和糖尿病并发症的关联:一项前瞻性队列研究

The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study.
PubMed 文献 · Diabetologia · 2017-08-03

研究纳入新诊断(<6个月)2型糖尿病的多民族基层医疗队列,基线PHQ-9和PAID可用的1651例中,抑郁症状者232例(14.1%)、糖尿病痛苦者111例(6.7%);校正混杂后抑郁症状与HbA1c恶化无关联,与主要心血管并发症发生风险升高相关(OR 2.78,95%CI 1.19,6.49,p=0.018),糖尿病痛苦与血糖恶化及并发症均无关联。

要点

  • 抑郁症状(PHQ-9≥10)与新诊断2型糖尿病2年内大血管并发症风险升高相关(OR 2.78)。
  • 抑郁症状与HbA1c恶化无关联,糖尿病痛苦与血糖恶化及并发症均无关联。
  • 校正IL-1受体拮抗剂浓度后上述关联减弱(p=0.09),作者认为需重复验证。

核心结论

  • 在新诊断2型糖尿病最初2年,抑郁症状和糖尿病痛苦对血糖控制的影响很小;但抑郁症状与大血管并发症发生率存在关联;固有炎症升高可能同时与抑郁和糖尿病大血管并发症相关,但这些发现需重复验证。

研究设计与样本

  • 多民族基层医疗前瞻性队列,共1735例近期(<6个月)诊断2型糖尿病的成人;其中1651例(95.2%)有基线PHQ-9和PAID评分纳入分析;采用多变量模型校正潜在混杂因素。

主要发现

  • 基线抑郁症状(PHQ-9≥10)232例(14.1%),糖尿病痛苦(PAID≥40)111例(6.7%);平均±SD年龄56.2±11.1岁,男性55.1%,非白人49.1%。
  • 校正混杂因素后,抑郁症状与HbA1c恶化无关联。
  • 校正年龄、性别、民族、血管危险因素和糖尿病治疗后,抑郁症状与大血管并发症发生风险升高相关(OR 2.78 [95% CI 1.19, 6.49],p=0.018),与微血管并发症无关联。
  • 校正IL-1受体拮抗剂浓度后,抑郁症状与大血管并发症的关联减弱(p=0.09)。
  • 糖尿病痛苦与HbA1c恶化或并发症发生均无关联。

局限性

  • 作者指出这些发现需重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We examined the associations between depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years, after diagnosis of type 2 diabetes. METHODS: In a multi-ethnic, primary care cohort (n = 1735) of adults, all with recent (<6 months) diagnosis of type 2 diabetes, we measured the associations between depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] score ≥10) and diabetes distress (Problem Areas in Diabetes [PAID] score ≥40), with change in 2 year HbA1c as the primary outcome and with incident rates of diabetes complications as secondary outcomes. Multivariate models were used to account for potential confounders. RESULTS: Of the 1651 participants (95.2%) of the total primary care cohort with available baseline PHQ-9 and PAID scores, mean ± SD age was 56.2 ± 11.1 years, 55.1% were men and 49.1% were of non-white ethnicity; 232 (14.1%) and 111 (6.7%) had depressive symptoms and diabetes distress, respectively. After adjustment for confounders, depressive symptoms were not associated with worsening HbA1c. After adjustment for age, sex, ethnicity, vascular risk factors and diabetes treatments, depressive symptoms were associated with increased risk of incident macrovascular complications (OR 2.78 [95% CI 1.19, 6.49], p = 0.018) but not microvascular complications. This was attenuated (p = 0.09) after adjustment for IL-1 receptor antagonist concentration. Diabetes distress was not associated with worsening HbA1c or incident complications. CONCLUSIONS/INTERPRETATION: In the first 2 years of type 2 diabetes, the effect of depressive symptoms and diabetes distress on glycaemic control is minimal. There was, however, an association between depressive symptoms and incidence of macrovascular complications. Elevated innate inflammation may be common to both depression and macrovascular diabetes complications, but these findings require replication.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ismail K, Moulton CD, Winkley K, et al. The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study. Diabetologia. 2017. PMID: 28776084. doi:10.1007/s00125-017-4367-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。